These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 29326927)

  • 1. Nanoparticles-Emerging Potential for Managing Leukemia and Lymphoma.
    Vinhas R; Mendes R; Fernandes AR; Baptista PV
    Front Bioeng Biotechnol; 2017; 5():79. PubMed ID: 29326927
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Clinical Translation of Organic Nanomaterials for Cancer Therapy: A Focus on Polymeric Nanoparticles, Micelles, Liposomes and Exosomes.
    Palazzolo S; Bayda S; Hadla M; Caligiuri I; Corona G; Toffoli G; Rizzolio F
    Curr Med Chem; 2018; 25(34):4224-4268. PubMed ID: 28875844
    [TBL] [Abstract][Full Text] [Related]  

  • 3. What Went Wrong with Anticancer Nanomedicine Design and How to Make It Right.
    Sun D; Zhou S; Gao W
    ACS Nano; 2020 Oct; 14(10):12281-12290. PubMed ID: 33021091
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeted nanomedicine for cancer therapeutics: Towards precision medicine overcoming drug resistance.
    Bar-Zeev M; Livney YD; Assaraf YG
    Drug Resist Updat; 2017 Mar; 31():15-30. PubMed ID: 28867241
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhanced permeability and retention of macromolecular drugs in solid tumors: a royal gate for targeted anticancer nanomedicines.
    Greish K
    J Drug Target; 2007; 15(7-8):457-64. PubMed ID: 17671892
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inorganic Nanoparticles for Cancer Therapy: A Transition from Lab to Clinic.
    Bayda S; Hadla M; Palazzolo S; Riello P; Corona G; Toffoli G; Rizzolio F
    Curr Med Chem; 2018; 25(34):4269-4303. PubMed ID: 29284391
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Progress of Cancer Nanotechnology as Diagnostics, Therapeutics, and Theranostics Nanomedicine: Preclinical Promise and Translational Challenges.
    Alshehri S; Imam SS; Rizwanullah M; Akhter S; Mahdi W; Kazi M; Ahmad J
    Pharmaceutics; 2020 Dec; 13(1):. PubMed ID: 33374391
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nanomedicines for the treatment of hematological malignancies.
    Deshantri AK; Varela Moreira A; Ecker V; Mandhane SN; Schiffelers RM; Buchner M; Fens MHAM
    J Control Release; 2018 Oct; 287():194-215. PubMed ID: 30165140
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Actively Targeted Nanoparticles for Drug Delivery to Tumor.
    Bi Y; Hao F; Yan G; Teng L; Lee RJ; Xie J
    Curr Drug Metab; 2016; 17(8):763-782. PubMed ID: 27335116
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Copper sulfide: An emerging adaptable nanoplatform in cancer theranostics.
    Poudel K; Gautam M; Jin SG; Choi HG; Yong CS; Kim JO
    Int J Pharm; 2019 May; 562():135-150. PubMed ID: 30904728
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bridging the Gap between Macroscale Drug Delivery Systems and Nanomedicines: A Nanoparticle-Assembled Thermosensitive Hydrogel for Peritumoral Chemotherapy.
    Huang P; Song H; Zhang Y; Liu J; Zhang J; Wang W; Liu J; Li C; Kong D
    ACS Appl Mater Interfaces; 2016 Nov; 8(43):29323-29333. PubMed ID: 27731617
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nanomedicines for Reactive Oxygen Species Mediated Approach: An Emerging Paradigm for Cancer Treatment.
    Kwon S; Ko H; You DG; Kataoka K; Park JH
    Acc Chem Res; 2019 Jul; 52(7):1771-1782. PubMed ID: 31241894
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Self-assembly of porphyrin-grafted lipid into nanoparticles encapsulating doxorubicin for synergistic chemo-photodynamic therapy and fluorescence imaging.
    Hameed S; Bhattarai P; Liang X; Zhang N; Xu Y; Chen M; Dai Z
    Theranostics; 2018; 8(19):5501-5518. PubMed ID: 30555560
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nanomedicine to overcome cancer multidrug resistance.
    Yang X; Yi C; Luo N; Gong C
    Curr Drug Metab; 2014; 15(6):632-49. PubMed ID: 25255871
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lipid-based drug delivery systems for cancer treatment.
    Arias JL; Clares B; Morales ME; Gallardo V; Ruiz MA
    Curr Drug Targets; 2011 Jul; 12(8):1151-65. PubMed ID: 21443475
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nanoparticles' interactions with vasculature in diseases.
    Tee JK; Yip LX; Tan ES; Santitewagun S; Prasath A; Ke PC; Ho HK; Leong DT
    Chem Soc Rev; 2019 Oct; 48(21):5381-5407. PubMed ID: 31495856
    [TBL] [Abstract][Full Text] [Related]  

  • 17. To exploit the tumor microenvironment: Since the EPR effect fails in the clinic, what is the future of nanomedicine?
    Danhier F
    J Control Release; 2016 Dec; 244(Pt A):108-121. PubMed ID: 27871992
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of surface grafting density of PEG macromolecules on dually fluorescent silica nanoparticles used for the in vivo imaging of subcutaneous tumors.
    Adumeau L; Genevois C; Roudier L; Schatz C; Couillaud F; Mornet S
    Biochim Biophys Acta Gen Subj; 2017 Jun; 1861(6):1587-1596. PubMed ID: 28179102
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Retrospective 30 Years After Discovery of the Enhanced Permeability and Retention Effect of Solid Tumors: Next-Generation Chemotherapeutics and Photodynamic Therapy--Problems, Solutions, and Prospects.
    Maeda H; Tsukigawa K; Fang J
    Microcirculation; 2016 Apr; 23(3):173-82. PubMed ID: 26237291
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Approaches to Improve EPR-Based Drug Delivery for Cancer Therapy and Diagnosis.
    Subhan MA; Parveen F; Filipczak N; Yalamarty SSK; Torchilin VP
    J Pers Med; 2023 Feb; 13(3):. PubMed ID: 36983571
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.